Influenza
Influenza is usually self-limiting, but complications such as pneumonia and bronchitis can be serious threats to newborns, the elderly, and people with chronic diseases. Epidemics of influenza (usually of type A), sometimes worldwide in scope, have decimated large populations (worldwide between 50 and 100 million people died in the great pandemic of 1918, some 675,000 in the United States alone). Type B is more likely to occur sporadically.
Because a number of different viral strains can cause the disease, immunity to one type does not prevent susceptibility to another. Influenza virus vaccine confers immunity to a particular strain and is recommended for persons at risk; unfortunately the surface antigens of flu viruses change periodically, making it necessary to reformulate the vaccine yearly in an educated guess at what strain will appear.
The antiviral drugs amantadine and rimantadine are effective against type A influenza, and zanamivir against types A and B. Treatment with antibiotics has greatly reduced fatalities from secondary infections. Uncomplicated influenza requires only rest and treatment of symptoms. Return to normal activity should be undertaken slowly, as relapses are easily precipitated.
See G. Kolata, Flu (1999); A. W. Crosby, America's Forgotten Pandemic (2d ed. 2003); J. M. Barry, The Great Influenza (2004).

